Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avonex was produced by Biogen Idec.

New accounts: January

Biogen. Avonex. Multiple sclerosis. Brader Perryman. Cambridge Laboratories. Gelclair. Oncology/ENT. RFA Advertising.

Double or quits!

Avonex (Biogen Idec) and Rebif (Serono) are recombinant human inter-feron B-1a products; administration is via subcutaneous (SC) injection once- and thrice-weekly, respectively. ... However, Avonex can also be used for a single neurological event

New accounts: February

Biogen. Avonex. Multiple sclerosis. Brader Perryman. Eden Biodesign. N/A. Corporate. Affiniti (UK).

Turbulent times

The companies revealed that one patient had died after taking Tysabri for two years in combination with Avonex while a second was suspected of developing a central nervous system disease.

Biogen Idec board may sell

Biogen's primary drug portfolio consists of multiple sclerosis (MS) drugs Avonex (interferon beta-1a) and Tysabri (natalizumab), as well as rheumatoid arthritis (RA) and cancer drug Rituxan (rituximab).

[ Previous 5 results ] 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...